• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

12.21 +0.30 (+2.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
September 22, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
September 14, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 02, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound (MDWD) Q2 2026 Earnings Call Transcript ↗
August 20, 2026
EscharEx advances Phase III enrollment while manufacturing facility nears regulatory completion. 
Via The Motley Fool
Topics Earnings
MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact ↗
May 27, 2026
Via Chartmill
MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress ↗
March 05, 2026
Via Chartmill
News headline image
MediWound Q2 Earnings Call Highlights ↗
August 13, 2026
MediWound (NASDAQ:MDWD) reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million a year earlier, as the company continued investing in its Phase III EscharEx chronic-wound program... 
Via MarketBeat
Topics Earnings
News headline image
MediWound Q2 2026 Earnings Call: Complete Transcript ↗
August 13, 2026
MediWound (NASDAQ:MDWD) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts... 
Via Benzinga
Topics Earnings
News headline image
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report Second Quarter 2026 Financial Results
July 29, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
May 27, 2026
MediWound (MDWD) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
MediWound Q1 Earnings Call Highlights ↗
May 27, 2026
MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance... 
Via MarketBeat
Topics Earnings
News headline image
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report First Quarter 2026 Financial Results
May 07, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
April 13, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
April 07, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Files Annual Report on Form 20-F
March 05, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound (MDWD) Q4 2025 Earnings Call Transcript ↗
March 05, 2026
MediWound (MDWD) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present at Upcoming Investor Conferences
February 17, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
January 12, 2026
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
December 10, 2025
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates ↗
November 20, 2025
MediWound's Q3 2025 results show revenue miss but a smaller-than-expected loss. The company advances its EscharEx pipeline and expands NexoBrid manufacturing. 
Via Chartmill
News headline image
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 20, 2025
From MediWound Ltd.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 20, 2025 ↗
November 20, 2025
 
Via Benzinga
News headline image
Examining the Future: MediWound's Earnings Outlook ↗
November 19, 2025
 
Via Benzinga
News headline image
MediWound to Report Third Quarter 2025 Financial Results
November 05, 2025
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
November 03, 2025
From MediWound Ltd.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap